This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/chinook-therapeutics-stock-novartis-buy-ed3f500e

Chinook Therapeutics Stock Surges After Novartis Agrees to $3.5 Billion Deal

By
Callum Keown
  • Order Reprints
  • Print Article

Chinook Therapeutics (KDNY) stock surged 66% in premarket trading Monday after Swiss pharmaceutical company Novartis (NVS) agreed to buy the biopharma company for up to $3.5 billion.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.